search

Erythropoiesis-stimulating agent should be considered in below set of patients

Erythropoiesis-stimulating agent should be considered in below set of patients:1

Change for Better...Change to

Abbreviations ▼

CKD: Chronic kidney disease; CVD: Cardiovascular disease; Hb: Hemoglobin; HRQoL: Health-related quality of life; KDIGO: Kidney Disease Improving Global Outcomes.

References ▼

LMRC Code: GGI-CO-A1-AQS-DCVN-BANNERS-I23-0349

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cresp 1

Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients

Know more
Cresp

Related Articles

Understanding Immunoglobulin A Nephropathy: From Multi-Hit Theory to Genetic Blueprint

Explore the complex pathogenesis of Immunoglobulin A nephropathy through the Multi-Hit Theory and discover how...

Advancing Care in Transplantation and ESA Resistance: Insights and Solutions

A comprehensive analysis of the evolving landscape of kidney disease treatments, focusing on xenotransplantation advancements...

Latest Advancements for Hyperkalemia Therapeutics in Non-Dialysis Chronic Kidney Disease

Stay informed about the latest therapeutic options for managing hyperkalemia in non-dialysis CKD.

Updates on New Therapies for Patients with CKD

Explore the latest therapies, including ARNI and finerenone, proven to slow CKD progression and protect...

Keep Up to Date: Discover the KDIGO 2024 Guidelines for CKD Management!

Learn the latest KDIGO recommendations for evaluating CKD risk in adults and managing stages G3-G5

RNS (Regional Nephrology Summit) Hyderabad

RNS (Regional Nephrology Summit) Bangalore

RNS (Regional Nephrology Summit) Chandigarh

Navigating Healthcare Legalities

RNS (Regional Nephrology Summit) Ahmedabad

Synergistic Effect Between Anemia and Hyperuricemia Increases Mortality Risk in CKD Patients

Efficacy and safety of etranacogene dezaparvovec gene therapy for haemophilia B

Enhanced health-related quality of life with ide-cel in relapsed and refractory multiple myeloma patients

R-CHOP treatment in advanced follicular lymphoma patients

Early Anemia Treatment in Nondialysis CKD Patients Reduces Cardiovascular Risks and Mortality

Renal Complications of Antidiabetic Drugs by Dr. Sreedhar Reddy

Detection and Evaluation of CKD by Dr. Rekha MC

Nephrotic Syndrome: Introduction by Dr. Prashant Malviya

Proteinuria in CKD by Dr. Prakash Khaitan

Renal Implications of Antidiabetic Drugs by Dr. John Abraham